Login / Signup

G protein-coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects.

Mydirah Littlepage-SaundersMichael J HochsteinDoris S ChangKari A Johnson
Published in: British journal of pharmacology (2023)
Dopamine transmission in the striatum is a critical mediator of the rewarding and reinforcing effects of commonly misused psychoactive drugs. G protein-coupled receptors (GPCRs) that bind a variety of neuromodulators including dopamine, endocannabinoids, acetylcholine, and endogenous opioid peptides regulate dopamine release by acting on several components of dopaminergic circuitry. Striatal dopamine release can be driven by both somatic action potential firing and local mechanisms that depend on acetylcholine released from striatal cholinergic interneurons. GPCRs that primarily regulate somatic firing of dopamine neurons via direct effects or modulation of synaptic inputs are likely to impact distinct aspects of behavior and psychoactive drug actions compared with GPCRs that primarily regulate local acetylcholine-dependent dopamine release in striatal regions. This review will highlight mechanisms by which GPCRs modulate dopaminergic transmission and the relevance of these findings to psychoactive drug effects on physiology and behavior.
Keyphrases
  • uric acid
  • prefrontal cortex
  • functional connectivity
  • parkinson disease
  • chronic pain
  • drug induced
  • copy number
  • spinal cord injury
  • climate change